WASHINGTON — Senate Democrats are vetting a new, tweaked version of a drug pricing package as they hurtle toward a September deadline to pass any major reforms.
It’s by no means certain that Congress will pass prescription drug pricing reform as part of a broader domestic policy package being hammered out between Senate Majority Leader Chuck Schumer and moderate Sen. Joe Manchin (D-W.V.), but this week, the chances are looking better than ever.
Negotiations have come a long way — last October, the White House claimed the Democratic chasm on drug pricing policy was just too hard to bridge. Now, it’s the most solid plank of a potential deal that both Schumer and Manchin agree on. Drug pricing reform is enormously politically popular, and also would save the federal government money.
Create a display name to comment
This name will appear with your comment